Anticomplement therapies in "secondary thrombotic microangiopathies": ready for prime time?

Affiliations

Free article

Editorial

Jai Radhakrishnan. Kidney Int. 2019 Oct.

Free article

. 2019 Oct;96(4):833-835.

doi: 10.1016/j.kint.2019.08.005.

¹ Department of Medicine, Columbia University, New York, New York, USA. Electronic address: jr55@cumc.columbia.edu.

No abstract available

Comment on

Complement inhibitors are useful in secondary hemolytic uremic syndromes.
Caravaca-Fontan F, Praga M. Caravaca-Fontan F, et al. Kidney Int. 2019 Oct;96(4):826-829. doi: 10.1016/j.kint.2019.07.006. Kidney Int. 2019. PMID: 31543153 No abstract available.
Complement inhibitors are not useful in secondary hemolytic uremic syndromes.
Duineveld C, Wetzels JFM. Duineveld C, et al. Kidney Int. 2019 Oct;96(4):829-833. doi: 10.1016/j.kint.2019.08.001. Kidney Int. 2019. PMID: 31543154 No abstract available.